Estrella Immunopharma, Inc.(ESLA)
Biotechnology
Cell Therapy (CAR-T, etc.)
| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership changeShares owned | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2025-09-11 | Xu Jiandong Chief Financial Officer | Purchase | +2,100 | +0.75%282,188 | $1.24 | $2,594 | View SEC filing | |
| 2022-03-17 | Li Jianwei Co-Chief Executive Officer | Purchase | +141,970 | +12.77%1,253,730 | $314700.00 | $44,677,959,000 | View SEC filing |
1-2 of 2